| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 5 | |
| #2 | Canada | 5 | |
| #3 | WIPO (World Intellectual Property Organization) | 5 | |
| #4 | Germany | 3 | |
| #5 | China | 2 | |
| #6 | EPO (European Patent Office) | 2 | |
| #7 | Mexico | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Environmental technology | |
| #3 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Unspecified technologies | |
| #4 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wagner Hildebert | 10 |
| #2 | Adam Dieter | 4 |
| #3 | Gebhardt Rolf | 4 |
| #4 | Endres Stefan | 4 |
| #5 | Manns Michael | 4 |
| #6 | Van Der Giessen Robert H M | 3 |
| #7 | Von Keudell Christoph | 3 |
| #8 | Tittel Gerolf | 3 |
| #9 | Vollmar Angelika | 3 |
| #10 | Wagner Hildebert K M | 3 |
| Publication | Filing date | Title |
|---|---|---|
| CA2424930A1 | Method for producing phyllanthus extracts | |
| AU2059402A | Phyllanthus-derived compounds for the prevention and/or treatment of diseases associated with a retrovirus | |
| DE10120627A1 | Use of phyllanthus components for the treatment or prophylaxis of infections caused by hepatitis B viruses | |
| DE10030139A1 | Use of phyllanthus components for the treatment or prophylaxis of Flaviviridae infections | |
| DE19919585A1 | Use of phyllanthus to treat oxidative stress and other symptoms |